Johnson & Johnson FDA Booster Request ‘Good News’ in COVID Fight, Expert Says

Johnson & Johnson on Tuesday announced it had submitted data to the Food and Drug Administration for authorization of a booster shot of its single-dose COVID-19 vaccine, marking the latest effort by vaccine makers to gain approval for a new round of inoculations.